These results demonstrate that quisinostat can stimulate SMARCA2-dependent IP3R3 expression to restore ER-Ca2+ release-induced mitochondrial Ca2+ flux and chemotherapy sensitivity in SMARCA4/2-deficient cancer cells. This evidence concerns the gene SMARCA2 and cancer.